Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer - Comparison of dose, toxicity and cost-effectiveness

Radiotherapy and Oncology

Volumn 118, Issue 2, 2016, Pages 281-285

  Cheng, Qing ^a   Roelofs, Erik ^a   Ramaekers, Bram L T ^b   Eekers, Daniëlle ^a   Van Soest, Johan ^a   Lustberg, Tim ^a   Hendriks, Tim ^a   Hoebers, Frank ^a   Van Der Laan, Hans Paul ^c   Korevaar, Erik W ^c   Dekker, Andre ^a   Langendijk, Johannes A ^c   Lambin, Philippe ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cost effectiveness estimation; Decision support system; Mean dose extraction; Proton therapy; Quantitative comparison; Toxicity prediction

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; DYSPHAGIA; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; PHOTON THERAPY; PRIORITY JOURNAL; PROTON RADIATION; QUALITY ADJUSTED LIFE YEAR; RADIATION DOSE; RADIATION INJURY; XEROSTOMIA; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; EVALUATION STUDY; HEAD AND NECK NEOPLASMS; PHOTON; PROCEDURES; PROTON THERAPY; RADIOTHERAPY DOSAGE; THERAPEUTIC USE;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; EVALUATION STUDIES AS TOPIC; HEAD AND NECK NEOPLASMS; HUMANS; PHOTONS; PROTON THERAPY; RADIOTHERAPY DOSAGE;

EID: 84960288475     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.12.029     Document Type: Article

References (51)

1. J.P. Grutters, A.G. Kessels, M. Pijls-Johannesma, D. De Ruysscher, M.A. Joore, and P. Lambin Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis Radiother Oncol 95 2010 32 40
2. P. Lambin, E. Roelofs, B. Reymen, and et al. Rapid Learning health care in oncology - an approach towards decision support systems enabling customised radiotherapy Radiother Oncol 109 2013 159 164
3. M. Pijls-Johannesma, J.P. Grutters, F. Verhaegen, P. Lambin, and D. De Ruysscher Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review Oncologist 15 2010 93 103
4. A. Peeters, J.P. Grutters, M. Pijls-Johannesma, and et al. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons Radiother Oncol 95 2010 45 53
5. P. Lambin, S.F. Petit, H.J. Aerts, E.S.T.R.O. The, Breur. Lecture, and et al. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer Radiother Oncol 2010 2009 145 152
6. P. Lambin, R.G. van Stiphout, M.H. Starmans, and et al. Predicting outcomes in radiation oncology-multifactorial decision support systems Nat Rev Clin Oncol 10 2013 27 40
7. P. Lambin, J. Zindler, B. Vanneste, and et al. Modern clinical research: how rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine Acta Oncol 2015 1 12
8. Proton radiotherapy. Horizon scanning report. Health Council of the Netherlands, 2009. Available from: http://www.gezondheidsraad.nl/sites/default/files/summary-200917.pdf.
9. M. Pijls-Johannesma, J.P. Grutters, P. Lambin, and D.D. Ruysscher Particle therapy in lung cancer: where do we stand? Cancer Treat Rev 34 2008 259 267
10. J.P. Grutters, K.R. Abrams, D. de Ruysscher, and et al. When to wait for more evidence? Real options analysis in proton therapy Oncologist 16 2011 1752 1761
11. M. Jermann Particle therapy statistics in 2014 Int J Part Ther 2 2015 50 54
12. E. Roelofs, M. Engelsman, C. Rasch, and et al. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer J Thorac Oncol 7 2012 165 176
13. H.P. van der Laan, T.A. van de Water, and H.E. van Herpt The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: a planning comparative study Acta Oncol 52 2013 561 569
14. E. Roelofs, L. Persoon, S. Qamhiyeh, and et al. Design of and technical challenges involved in a framework for multicentric radiotherapy treatment planning studies Radiother Oncol 97 2010 567 571
15. A. Luhr, S. Lock, K. Roth, and et al. Concept for individualized patient allocation: ReCompare-remote comparison of particle and photon treatment plans Radiat Oncol 9 2014 59
16. S. Lock, K. Roth, T. Skripcak, and et al. Implementation of a software for REmote COMparison of PARticlE and photon treatment plans: ReCompare Z Med Phys 25 2015 287 294
17. J.E. Bekelman, D.A. Asch, Z. Tochner, and et al. Principles and reality of proton therapy treatment allocation Int J Radiat Oncol Biol Phys 89 2014 499 508
18. M.C. Pijls-Johannesma, D.K. de Ruysscher, and A.L. Dekker Lambin P Protons and ions in the treatment of cancer; a systematic review of the literature Ned Tijdschr Geneeskd 150 2006 2435 2441
19. J.P. Grutters, M. Pijls-Johannesma, D.D. Ruysscher, and et al. The cost-effectiveness of particle therapy in non-small cell lung cancer: exploring decision uncertainty and areas for future research Cancer Treat Rev 36 2010 468 476
20. J.A. Langendijk, P. Lambin, D. De Ruysscher, J. Widder, M. Bos, and M. Verheij Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach Radiother Oncol 107 2013 267 273
21. J. Widder, A. van der Schaaf, P. Lambin, and et al. The quest for evidence for proton therapy: the model-based approach and precision medicine Int J Radiat Oncol Biol Phys 2015
22. C. Grau The model-based approach to clinical studies in particle radiotherapy-a new concept in evidence based radiation oncology? Radiother Oncol 107 2013 265 266
23. B.L. Ramaekers, J.P. Grutters, M. Pijls-Johannesma, P. Lambin, M.A. Joore, and J.A. Langendijk Protons in head-and-neck cancer: bridging the gap of evidence Int J Radiat Oncol Biol Phys 85 2013 1282 1288
24. Q. Cheng, E. Roelofs, B. Ramaekers, and et al. Data from: development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer - comparison of dose. Toxicity and Cost-Effectiveness Cancer Data 2015 10.17195/candat.2015.10.5
25. G.S. Collins, J.B. Reitsma, D.G. Altman, and K.G. Moons Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement Eur J Clin Invest 45 2015 204 214
26. M.E. Christianen, C. Schilstra, I. Beetz, and et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study Radiother Oncol 105 2012 107 114
27. I. Beetz, C. Schilstra, F.R. Burlage, and et al. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors Radiother Oncol 105 2012 86 93
28. J.O. Deasy, V. Moiseenko, L. Marks, K.S. Chao, J. Nam, and A. Eisbruch Radiotherapy dose-volume effects on salivary gland function Int J Radiat Oncol Biol Phys 76 2010 S58 63
29. T. Rancati, M. Schwarz, A.M. Allen, and et al. Radiation dose-volume effects in the larynx and pharynx Int J Radiat Oncol Biol Phys 76 2010 S64 69
30. P.C. Levendag, D.N. Teguh, P. Voet, and et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship Radiother Oncol 85 2007 64 73
31. Consensus document voor selectie van patiënten met een model-based indicatie voor protonen therapie (Unpublished internal document). Landelijk Platform Protonen Therapie (LPPT), 2015.
32. Sensible and sustainable care. Council for Public Health and Care (RVZ), 2006. Available from: http://www.raadrvs.nl/uploads/docs/Sensible-and-sustainable-care.pdf.
33. J. Van Soest, T. Lustberg, D. Grittner, and et al. Towards a semantic PACS: using Semantic Web technology to represent imaging data Stud Health Technol Inform 205 2014 166 170
34. B. Seroussi, A. Soulet, N. Messai, C. Laouenan, F. Mentre, and J. Bouaud Patient clinical profiles associated with physician non-compliance despite the use of a guideline-based decision support system: a case study with OncoDoc2 using data mining techniques AMIA Annu Symp Proc 2012 2012 828 837
35. S.R. Steele, A. Bilchik, E.K. Johnson, and et al. Time-dependent estimates of recurrence and survival in colon cancer: clinical decision support system tool development for adjuvant therapy and oncological outcome assessment Am Surg 80 2014 441 453
36. Bongers ML dRD, Oberije C, Lambin P, Uyl-de Groot CA, Belderbos J, Coupé VHM. Calibration of a micro-simulation model to assess cost-effectiveness of conventional and innovative chemoradiation schemes in non-small cell lung cancer In process.
37. B.G. Vanneste, M. Pijls-Johannesma, L. Van De Voorde, and et al. Spacers in radiotherapy treatment of prostate cancer: is reduction of toxicity cost-effective? Radiother Oncol 114 2015 276 281
38. A. Jakobi, A. Bandurska-Luque, K. Stutzer, and et al. Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis Int J Radiat Oncol Biol Phys 92 2015 1165 1174
39. CancerData.org. EuroCAT Umbrella Protocol for NSCLC 2015 [cited 2015 6 Oct]. Available from: https://www.cancerdata.org/protocols/eurocat-umbrella-protocol-nsclc.
40. E. Meldolesi, J. van Soest, N. Dinapoli, and et al. An umbrella protocol for standardized data collection (SDC) in rectal cancer: a prospective uniform naming and procedure convention to support personalized medicine Radiother Oncol 112 2014 59 62
41. C. Melidis, W.R. Bosch, J. Izewska, and et al. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials Int J Radiat Oncol Biol Phys 90 2014 1242 1249
42. L. Santanam, C. Hurkmans, S. Mutic, and et al. Standardizing naming conventions in radiation oncology Int J Radiat Oncol Biol Phys 83 2012 1344 1349
43. P.W. Voet, M.L. Dirkx, S. Breedveld, D. Fransen, P.C. Levendag, and B.J. Heijmen Toward fully automated multicriterial plan generation: a prospective clinical study Int J Radiat Oncol Biol Phys 85 2013 866 872
44. A.C. Kraan, S. van de Water, and D.N. Teguh Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors Int J Radiat Oncol Biol Phys 87 2013 888 896
45. S.F. Petit, B. Wu, M. Kazhdan, and et al. Increased organ sparing using shape-based treatment plan optimization for intensity modulated radiation therapy of pancreatic adenocarcinoma Radiother Oncol 102 2012 38 44
46. Frank SJ, Rosenthal DI, Ang K, et al. Gastrostomy Tubes Decrease by Over 50% With Intensity Modulated Proton Therapy (IMPT) During the Treatment of Oropharyngeal Cancer Patients: A Case-Control Study. Proceedings of the American Society for Radiation Oncology 55th Annual Meeting ASTRO's 55th Annual Metting 2013;87.
47. J.O. Deasy, S.M. Bentzen, A. Jackson, and et al. Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture Int J Radiat Oncol Biol Phys 76 2010 S151 154
48. A. Dekker, G. Nalbantov, C. Oberije, and et al. Multi-centric learning with a federated IT infrastructure: application to 2-year lung-cancer survival prediction Radiother Oncol 106 2013 Mar S193
49. T. Skripcak, C. Belka, W. Bosch, and et al. Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets Radiother Oncol 113 2014 303 309
50. L. Fachal, A. Gomez-Caamano, G.C. Barnett, and et al. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1 Nat Genet 46 2014 891 894
51. G.C. Barnett, D. Thompson, L. Fachal, and et al. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity Radiother Oncol 111 2014 178 185